U.S. Markets close in 2 hrs 47 mins

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.350+0.050 (+0.943%)
As of 1:11PM EDT. Market open.
People also watch
Full screen
Previous Close5.300
Bid5.350 x 6400
Ask5.400 x 200
Day's Range5.300 - 5.425
52 Week Range3.300 - 6.900
Avg. Volume125,376
Market Cap150.38M
PE Ratio (TTM)-11.86
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 months ago

    ETFs with exposure to CytoSorbents Corp. : May 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CytoSorbents Corp. Here are 5 ETFs with the largest exposure to CTSO-US. Comparing the performance and risk of CytoSorbents Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Zacks Small Cap Research2 months ago

    CTSO: Revenue Acceleration Expected 2H. REFRESH Efficacy Compelling

    By Brian Marckx, CFA NASDAQ:CTSO Q1 Financials / Operating Update: Slight Miss But Revenue Remains Robust. Expect Acceleration 2H …  CytoSorbents (NASDAQ:CTSO) reported financial results for the first ...

  • CytoSorbents Corp. :CTSO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube2 months ago

    CytoSorbents Corp. :CTSO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis CytoSorbents Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CytoSorbents Corp. – Boston Scientific Corporation and Meridian Bioscience, Inc. (BSX-US and VIVO-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 3.11 million, Net ... Read more (Read more...)